220
(The Center Square) – U.S. House oversight lawmakers reviewing the FDA’s role in the baby formula shortage say the federal agency is dodging oversight and delaying providing answers.
Subcommittee on Health Care and Financial Services Chairwoma
Already a subscriber? Log in here
Or, subscribe for unlimited access